Initiator Pharma A/S: Financial statements 2020
CVR: 37663808
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Initiator Pharma A/S (CVR 37663808) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -9,299,000 and a net result of DKK -8,697,000 compared with DKK -8,288,000 the year before. Equity in the 2020 report amounted to DKK 14,409,000. The solvency ratio was 92.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -9,299,000
- Profit/Loss
- DKK -8,697,000
- Equity
- DKK 14,409,000
- Total Assets
- DKK 15,603,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -9.3M | -8.7M | 14.4M | 1 |
| 2019 | - | -8.4M | -8.3M | 9.9M | 1 |
| 2018 | - | -11.4M | -10.3M | 16.6M | 1 |
| 2017 | - | -8.2M | -8.6M | 6M | 2 |
Official annual report
How creditworthy is Initiator Pharma A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Initiator Pharma A/S has published its annual report for 2019. Gross profit came to DKK -8,366,000, and the net result was DKK -8,288,000.
About Initiator Pharma A/S
Initiator Pharma A/S is a Danish company of the type Aktieselskab based in København N, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Elsborg Olesen. The board consists of Gunnar Magnus Severus Modée Persson (chair), Annette Ingegerd Marie Colin, Claus Elsborg Olesen and Majken Christina Östberg Lloyd. The company is owned by Linc AB and Adrigo Asset Management. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000.
